Laurence James Neil Cooper's most recent trade in Alaunos Therapeutics Inc was a trade of 105,693 Common Stock done at an average price of $2.7 . Disclosure was reported to the exchange on Jan. 4, 2021.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Alaunos Therapeutics Inc | Laurence James Neil Cooper | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 2.71 per share. | 04 Jan 2021 | 105,693 | 1,799,280 (0%) | 0% | 2.7 | 286,428 | Common Stock |